程序性细胞死亡受体1 与妊娠及相关疾病的研究进展
作者:
作者单位:

1.黑龙江中医药大学,哈尔滨 150006;2.黑龙江中医药大学附属第一医院,哈尔滨 150040

中图分类号:

R-33


Research progress of programmed cell death receptor 1 in pregnancy and related diseases
Author:
Affiliation:

1. Heilongjiang University of Chinese Medicine, Haerbin 150006, China. 2. First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Haerbin 150040

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    程序性细胞死亡受体1(programmed cell death protein 1,PD-1)是一种重要的免疫检查点分子,可以通过调节免疫系统对人体细胞的反应,抑制T 细胞炎症活动来调节免疫系统并促进自身免疫耐受。近年来研究发现,PD-1 在调节母胎免疫耐受,维持妊娠方面具有重要的作用。本文就PD-1 的来源、分布、生物学特点及在正常妊娠中的作用,以及PD-1 表达异常在子痫前期、复发性流产等妊娠相关疾病发病机制中的研究进展做一综述,为早期预防、早期诊断和及时治疗提供理论依据。

    Abstract:

    Programmed cell death protein 1 (PD-1) is an important immune checkpoint molecule that regulates the immune system and promotes autoimmune tolerance by regulating the immune response to human cells and inhibiting the inflammatory activity of T cells. Recent studies have found that PD-1 plays an important role in regulating maternal and fetal immune tolerance and maintaining pregnancy. This article reviews the source, distribution, and biological characteristics of PD-1 and its role in normal pregnancy as well as the research progress of abnormal PD-1 expression in the pathogenesis of pregnancy-related diseases such as pre-eclampsia and recurrent abortion to provide a theoretical basis for early prevention, early diagnosis, and timely treatment.

    参考文献
    相似文献
    引证文献
引用本文

陈 碗,任 雪,姜天悦,冯晓玲.程序性细胞死亡受体1 与妊娠及相关疾病的研究进展[J].中国比较医学杂志,2023,33(5):77~84.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-07-27
  • 在线发布日期: 2023-06-15
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭